By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

OncoMed Pharmaceuticals, Inc. 

800 Chesapeake Drive

Redwood City  California  94063  U.S.A.
Phone: 650-995-8200 Fax: 650-298-8600


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
Notch3 Biomarker Results And Updated Data From OncoMed Pharmaceuticals, Inc. (OMED)'s Phase Ib/II PINNACLE Clinical Trial Accepted For Presentation At The 16th World Conference On Lung Cancer 8/27/2015 7:17:58 AM
OncoMed Pharmaceuticals, Inc. (OMED) Announces Second Quarter 2015 Financial Results And Updates Demcizumab Phase Ib Non-Small Cell Lung Cancer Survival Data 8/11/2015 7:44:07 AM
OncoMed Pharmaceuticals, Inc. (OMED) To Report Second Quarter 2015 Financial Results On Monday, August 10, 2015 8/6/2015 11:06:19 AM
OncoMed Pharmaceuticals, Inc. (OMED) Initiates Phase I Clinical Trial For Anti-RSPO3 Antibody 7/28/2015 7:02:03 AM
OncoMed Pharmaceuticals, Inc. (OMED) To Present At The Cantor Fitzgerald Inaugural Healthcare Conference 7/6/2015 7:19:54 AM
OncoMed Pharmaceuticals, Inc. (OMED) Appoints Rick Winningham To Board Of Directors 6/29/2015 7:40:33 AM
ASCO15: OncoMed Pharmaceuticals, Inc. (OMED) Presents Phase 1b Clinical Trial Data For Tarextumab In Small Cell Lung Cancer At The 2015 ASCO Annual Meeting 6/1/2015 8:07:28 AM
ASCO15: OncoMed Pharmaceuticals, Inc. (OMED) Presents Updated Demcizumab Data In Non-Small Cell Lung Cancer At The 2015 ASCO Annual Meeting 6/1/2015 8:06:25 AM
ASCO15: OncoMed Pharmaceuticals, Inc. (OMED) Presents Data From Phase Ib Trial Of Demcizumab In Pancreatic Cancer At The 2015 ASCO Annual Meeting 6/1/2015 8:00:51 AM
OncoMed Pharmaceuticals, Inc. (OMED) To Present At Upcoming Investment Conferences 5/29/2015 11:06:41 AM
12345678910...
//-->